Japan BD will be exhibiting at the "31st Annual Meeting of the Japan PDA Pharmaceutical Science Society (Tokyo)" held at Tower Hall Funabori. This year's meeting will focus on themes related to pharmaceutical and formulation technology, as well as GMP and validation, featuring special lectures and general presentations over two days, alongside symposiums. Topics such as regulatory science and examples of validation implementation will be presented. This year's theme is "Stable Supply - Ensuring Quality and New Technologies." Exhibits will include BD's drug delivery systems (DDS) for injectable drugs, testing services required for combination drug development, and media for quality control. We sincerely look forward to your visit.

We have released Lesson 3 of the web course "Key Points Explanation: Media Performance Testing Manual." Lesson 3 is titled "18th Revision of the Japanese Pharmacopoeia: 4.05 Microbial Limit Testing - Media Performance Testing in Specific Microbial Tests." ≪What is the "Key Points Explanation: Media Performance Testing Manual"?≫ This is a series where experts clearly explain key points for each test, covering the basics to applications of media performance testing. We will provide you with "essential points to keep in mind" for reliable and efficient quality control. Please feel free to stop by.

We have launched a dedicated website for our microbiological testing solutions for pharmaceuticals, titled "Global Media Brand BD BBL (TM) Media / BD Difco (TM) Media in Compliance with the Pharmacopoeia of the Three Regions." As an information site for the global media brands BD BBL (TM) Media / BD Difco (TM) that comply with the standards of the Japanese Pharmacopoeia, United States Pharmacopeia, and European Pharmacopoeia, we will continue to enhance our content. If you have any inquiries or need product information (data, etc.), please feel free to contact us. A dedicated representative will assist you. We appreciate your continued support of Japan BD.